| Managing the Liabilities Arising from Structural Alerts: A Safe Philosophy for Medicinal Chemists. | |
| | |
MedLine Citation:
|
PMID: 21651480 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Bioactivation of xenobiotics can, in certain circumstances, result in the formation of reactive electrophilic species. These reactive metabolites may covalently modify proteins and macromolecules and it has been suggested that protein modification is a key initial step in provoking idiosyncratic adverse drug reactions. Understanding these bioactivation pathways is critical in order to rationally design drug candidates with a lower propensity to form reactive intermediates. Herein, we provide an overview of the importance of Structural Alerts and bioactivation pathways and describe the creation of an in-house database as a tool aimed at informing medicinal chemists about these potential liabilities. |
| | |
Authors:
|
P J Edwards; C Sturino |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-6-8 |
Journal Detail:
|
Title: Current medicinal chemistry Volume: - ISSN: 1875-533X ISO Abbreviation: - Publication Date: 2011 Jun |
Date Detail:
|
Created Date: 2011-6-9 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9440157 Medline TA: Curr Med Chem Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Boehringer Ingelheim (Canada) Limited, 2100 Cunard Street, Laval (Québec), H7S 2G5, Canada. paul.edwards@boehringer-ingelheim.com. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Irreversible Protein Kinase Inhibitors.
Next Document: Biological Potential and Structure-Activity Relationships of Most Recently Developed Vascular Disrup...